Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients

Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients

VJHemOnc

4 years
249 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an symposium on the role of tuberculosis (TB) and cytomegalovirus (CMV) immunodiagnostics in hematopoietic cell transplant recipients. The theme of the symposium was to look at immunotesting, specifically the T-SPOT.TB and T-SPOT.CMV assays, and how they can help to better predict and diagnose TB and CMV in patients. Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
Up Next Autoplay